Association between PD-1 inhibitor-related adverse events and frailty assessed by frailty index in lung cancer patients.
Cancer Med. 2023 Feb 2. doi: 10.1002/cam4.5669. Online ahead of print.
Cancer Med. 2023.
PMID: 36727563